These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27015273)

  • 1. FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.
    Peng X; Li SS; Gilbert PB; Geraghty DE; Katze MG
    PLoS One; 2016; 11(3):e0152425. PubMed ID: 27015273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
    Li SS; Gilbert PB; Carpp LN; Pyo CW; Janes H; Fong Y; Shen X; Neidich SD; Goodman D; deCamp A; Cohen KW; Ferrari G; Hammer SM; Sobieszczyk ME; Mulligan MJ; Buchbinder SP; Keefer MC; DeJesus E; Novak RM; Frank I; McElrath MJ; Tomaras GD; Geraghty DE; Peng X
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31434737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.
    Li SS; Gilbert PB; Tomaras GD; Kijak G; Ferrari G; Thomas R; Pyo CW; Zolla-Pazner S; Montefiori D; Liao HX; Nabel G; Pinter A; Evans DT; Gottardo R; Dai JY; Janes H; Morris D; Fong Y; Edlefsen PT; Li F; Frahm N; Alpert MD; Prentice H; Rerks-Ngarm S; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Robb ML; O'Connell RJ; Haynes BF; Michael NL; Kim JH; McElrath MJ; Geraghty DE
    J Clin Invest; 2014 Sep; 124(9):3879-90. PubMed ID: 25105367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HIV Vaccine Protective Allele in
    Ebonwu J; Lassaunière R; Paximadis M; Goosen M; Strehlau R; Gray GE; Kuhn L; Tiemessen CT
    Front Immunol; 2021; 12():760571. PubMed ID: 34917081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability at the FCGR locus: characterization in Black South Africans and evidence for ethnic variation in and out of Africa.
    Lassaunière R; Tiemessen CT
    Genes Immun; 2016 Mar; 17(2):93-104. PubMed ID: 26673965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression.
    Lassaunière R; Paximadis M; Ebrahim O; Chaisson RE; Martinson NA; Tiemessen CT
    Genes Immun; 2019 Nov; 20(8):651-659. PubMed ID: 30563969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.
    Prentice HA; Ehrenberg PK; Baldwin KM; Geretz A; Andrews C; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; O'Connell RJ; Robb ML; Kim JH; Michael NL; Thomas R
    Immunogenetics; 2014 May; 66(5):299-310. PubMed ID: 24682434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles.
    van der Heijden J; Breunis WB; Geissler J; de Boer M; van den Berg TK; Kuijpers TW
    J Immunol; 2012 Feb; 188(3):1318-24. PubMed ID: 22198951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive Ethnic Variation and Linkage Disequilibrium at the
    Nagelkerke SQ; Tacke CE; Breunis WB; Tanck MWT; Geissler J; Png E; Hoang LT; van der Heijden J; Naim ANM; Yeung RSM; Levin ML; Wright VJ; Burgner DP; Ponsonby AL; Ellis JA; Cimaz R; Shimizu C; Burns JC; Fijnvandraat K; van der Schoot CE; van den Berg TK; de Boer M; Davila S; Hibberd ML; Kuijpers TW;
    Front Immunol; 2019; 10():185. PubMed ID: 30949161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations.
    Lassaunière R; Tiemessen CT
    Front Immunol; 2021; 12():788203. PubMed ID: 34975881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.
    Lejeune J; Piègu B; Gouilleux-Gruart V; Ohresser M; Watier H; Thibault G
    MAbs; 2012; 4(6):784-7. PubMed ID: 23032993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.
    Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS
    Front Immunol; 2019; 10():390. PubMed ID: 30899264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1.
    Shangguan S; Ehrenberg PK; Geretz A; Yum L; Kundu G; May K; Fourati S; Nganou-Makamdop K; Williams LD; Sawant S; Lewitus E; Pitisuttithum P; Nitayaphan S; Chariyalertsak S; Rerks-Ngarm S; Rolland M; Douek DC; Gilbert P; Tomaras GD; Michael NL; Vasan S; Thomas R
    Elife; 2021 Sep; 10():. PubMed ID: 34533134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination.
    Lemke MM; Theisen RM; Bozich ER; McLean MR; Lee CY; Lopez E; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kratochvil S; Wines BD; Hogarth PM; Kent SJ; Chung AW; Arnold KB
    Front Immunol; 2022; 13():820148. PubMed ID: 35273603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.
    Gartland AJ; Li S; McNevin J; Tomaras GD; Gottardo R; Janes H; Fong Y; Morris D; Geraghty DE; Kijak GH; Edlefsen PT; Frahm N; Larsen BB; Tovanabutra S; Sanders-Buell E; deCamp AC; Magaret CA; Ahmed H; Goodridge JP; Chen L; Konopa P; Nariya S; Stoddard JN; Wong K; Zhao H; Deng W; Maust BS; Bose M; Howell S; Bates A; Lazzaro M; O'Sullivan A; Lei E; Bradfield A; Ibitamuno G; Assawadarachai V; O'Connell RJ; deSouza MS; Nitayaphan S; Rerks-Ngarm S; Robb ML; Sidney J; Sette A; Zolla-Pazner S; Montefiori D; McElrath MJ; Mullins JI; Kim JH; Gilbert PB; Hertz T
    J Virol; 2014 Aug; 88(15):8242-55. PubMed ID: 24829343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?
    Lamptey H; Bonney EY; Adu B; Kyei GB
    Front Immunol; 2021; 12():656894. PubMed ID: 34017334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping Single Nucleotide Polymorphisms and Copy Number Variability of the FCGRs Expressed on NK Cells.
    Erbe AK; Wang W; Gallenberger M; Hank JA; Sondel PM
    Methods Mol Biol; 2016; 1441():43-56. PubMed ID: 27177655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection.
    Kim JH; Excler JL; Michael NL
    Annu Rev Med; 2015; 66():423-37. PubMed ID: 25341006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.
    Dommaraju K; Kijak G; Carlson JM; Larsen BB; Tovanabutra S; Geraghty DE; Deng W; Maust BS; Edlefsen PT; Sanders-Buell E; Ratto-Kim S; deSouza MS; Rerks-Ngarm S; Nitayaphan S; Pitisuttihum P; Kaewkungwal J; O'Connell RJ; Robb ML; Michael NL; Mullins JI; Kim JH; Rolland M
    PLoS One; 2014; 9(10):e111334. PubMed ID: 25350851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.